Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Rigicon Infla10® Three-Piece Inflatable Penile Prosthesis (ERASE ED)

NCT: NCT05574868 · RECRUITING

NCT IDNCT05574868
StatusRECRUITING
Start Date2025-01-16
Completion2028-08-01
SponsorRigicon, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

This study evaluates the long-term safety and efficacy of the use of the Rigicon Infla 10® Three-Piece Inflatable Penile Prosthesis in patients with erectile dysfunction. This study follows patients implanted with the Rigicon Infla 10® Three-Piece Inflatable Penile Prosthesis for up to 3 years after implantation. This study will take approximately 6 months to enroll all subjects. (14 days, 6 weeks, 6 months, 12 months,18 months, 24 months, and 36 months, post-procedure. ) Subjects will be followed per protocol and institutional standard of care for ED and comorbidities.

Frequently Asked Questions

What is Rigicon Infla10® Three-Piece Inflatable Penile Prosthesis (ERASE ED)?

Rigicon Infla10® Three-Piece Inflatable Penile Prosthesis (ERASE ED) is a clinical trial registered under NCT05574868. Current status: RECRUITING.

What is the status of NCT05574868?

The current status of NCT05574868 (Rigicon Infla10® Three-Piece Inflatable Penile Prosthesis (ERASE ED)) is: RECRUITING.

When did Rigicon Infla10® Three-Piece Inflatable Penile Prosthesis (ERASE ED) start?

Rigicon Infla10® Three-Piece Inflatable Penile Prosthesis (ERASE ED) started on 2025-01-16.

Related Devices

K181673Rigi10 Malleable Penile ProsthesisRigicon, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑